Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
The length of hospital stays after HSCT was observed to be shorter following the introduction of letermovir in this study. This reduction in hospital stays did not decrease hospitalization costs in relation to allogeneic HSCT, but it may alleviate the burden on both patients and healthcare providers.
Authors
- S Tabata (ORCID: https://orcid.org/0000-0001-6240-4391)
- Ke Wan (ORCID: https://orcid.org/0000-0002-1563-7181)
- Toshiki Mushino (ORCID: https://orcid.org/0000-0001-7700-5262)
- Hiroki Hosoi (ORCID: https://orcid.org/0000-0002-8682-7476)
- Akinori Nishikawa (ORCID: https://orcid.org/0000-0001-9286-6909)
- Misato Tane
- Tadashi Okamura (ORCID: https://orcid.org/0000-0001-8457-1561)
- Shogo Murata (ORCID: https://orcid.org/0000-0001-8060-6683)
- Takashi Sonoki (ORCID: https://orcid.org/0000-0002-0211-3311)
Institutions
- Wakayama Medical University (JP)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1111/tid.70008
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Takeda Science Foundation
- Japan Society for the Promotion of Science